Skip to main content
CBT
NYSE Industrial Applications And Services

Outgoing CEO Keohane Files to Sell Another $11.5M in Cabot Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Negative
Importance info
7
Price
$84.425
Mkt Cap
$4.359B
52W Low
$58.33
52W High
$94.53
52W Position info
45% above low
Off High info
11% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

CBT sits 45% above its 52-week low of $58.33 on light trading volume (0.3× avg).

Summary

Outgoing CEO Sean Keohane filed to sell $11.47 million in Cabot shares acquired via option exercise, adding to his recent $8.18 million in sales as he prepares to retire on September 30.


Key Events · Ownership and Investor Activity · CBT

  • CEO Files to Sell $11.47M in Shares

    Sean Keohane filed a Form 144 to sell 134,895 shares (~$11.47M) acquired via option exercise on August 28, 2026.

  • Total 3-Month Selling Reaches $19.6M

    Combined with his $7.94M sale on August 7 and $237,604 sale on August 24, Keohane's disclosed sales total approximately $19.6 million.

  • Retirement Transition Underway

    Keohane retires as CEO on September 30, 2026, succeeded by CFO Erica McLaughlin; the sales are part of his planned exit.

  • Follows $350M Debt Offering

    The filing comes days after Cabot completed a $350 million senior notes offering due 2029, adding to near-term capital markets activity.


Analysis · CBT · Industrial Applications And Services

Outgoing CEO Sean Keohane has filed a new Form 144 to sell 134,895 shares worth approximately $11.47 million, acquired via option exercise on August 28, 2026. This follows his $7.94 million sale on August 7 and a smaller $237,604 sale on August 24, bringing his total disclosed selling activity over the past three months to roughly $19.6 million. The sale is part of his planned exit ahead of his September 30 retirement, but the size and timing — just days after the company completed a $350 million debt offering — add to the overhang on the stock.

How filings like this one have moved

In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CBT was trading at $84.43 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $4.4B. The 52-week trading range was $58.33 to $94.53. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CBT - Latest Insights

CBT
Aug 07, 2026, 3:19 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $87.38
Real-time Price: $79.13 info
Change: -$8.25 (-9%) info
Market Cap: $4.086B info
CBT
Aug 04, 2026, 2:58 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $81.20
Real-time Price: $79.13 info
Change: -$2.07 (-3%) info
Market Cap: $4.086B info
CBT
Aug 03, 2026, 4:52 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $89.58
Real-time Price: $79.13 info
Change: -$10.45 (-12%) info
Market Cap: $4.086B info
CBT
Aug 03, 2026, 4:39 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $79.83
Real-time Price: $79.13 info
Change: -$0.700 (-0.88%) info
Market Cap: $4.086B info
CBT
Aug 03, 2026, 4:36 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $89.58
Real-time Price: $79.13 info
Change: -$10.45 (-12%) info
Market Cap: $4.086B info